New Bill Would Mandate Public Access to CRS Reports
A bill introduced in the House of Representatives last month would require that certain reports of the Congressional Research Service be made publicly available online.
The “Congressional Research Accessibility Act” (HR 2545) was introduced on May 24 by Rep. Christopher Shays (R-CT), along with Reps. Jay Inslee (D-WA) and David Price (D-NC). (The bill was flagged by the Coalition of Journalists for Open Government.)
The proposed legislation does not offer everything one might hope for. In particular, it would prohibit public access to CRS reports until 30 days after they are first published on the internal congressional web site.
This is good news for commercial vendors of CRS products, who have (unauthorized) near-real time access to CRS publications and could continue to exploit that advantage for financial gain. But the delay would significantly diminish the utility of many such publications for the general public.
For example, on June 5, CRS issued a report on “Extensively Drug-Resistant Tuberculosis (XDR-TB): Quarantine and Isolation” (pdf), which was then the subject of current news interest.
Under the proposed legislation, this report would not become widely available to the public for more than three weeks from now when, one may hope, it will be old news. (It was obtained independently and published previously by the Center for Democracy and Technology’s OpenCRS.)
Confidential reports and responses to individual member requests would understandably not be released under the new proposal unless the requester chose to release them. But neither would other CRS products that are not confidential if they do not fit the proposed definition of what is to be released.
That might be the case, for example, with this new non-report tabulation of “Overt U.S. Assistance to Pakistan, FY2001-FY2008” (pdf), June 2007.
The congressional sponsors of the new bill, apparently fearing that CRS’ sharp analytical tools could be blunted by contact with their dull constituents, insist that CRS reports shall be published “in a manner that … does not permit the submission of comments from the public.”
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.
To ensure an energy transition that brings broad based economic development, participation, and direct benefits to communities, we need federal policy that helps shape markets. Unfortunately, there is a large gap in understanding of how to leverage federal policy making to support access to capital and credit.
From use to testing to deployment, the scaffolding for responsible integration of AI into high-risk use cases is just not there.
OPM’s new HR 2.0 initiative is entering hostile terrain. Those who have followed federal HR modernization for years desperately want this effort to succeed.